Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

9.26
Delayed Data
As of Mar 27
 +0.11 / +1.20%
Today’s Change
8.34
Today|||52-Week Range
17.69
-35.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues31.3M32.7M33.9M50.2M
 
 
 
 
 
Cost of Goods Sold0.00129.0K0.001.6M
 
 
 
Depreciation And Amortization2.0M2.1M1.9M--
 
 
 
 
 
Operating ExpensesGross Income29.3M30.5M32.0M48.6M
 
 
 
 
 
General Expenses40.0M57.9M52.4M103.9M
 
 
 
 
 
Other Operating Expenses0.000.000.002.3M
 
 
Research And Development29.0M44.5M28.0M19.2M
 
 
 
 
 
Total Operating Expenses42.0M60.2M54.3M107.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-27.4M-20.4M-57.6M
 
 
 
 
 
Extraordinary Credit0.000.000.0077.6M
 
 
Extraordinary Charge0.00-800.0K0.00--
 
 
Other Expenses0.000.00145.0K124.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-27.7M-20.3M20.2M
 
 
 
 
 
Income Taxes-444.0K0.000.00--
 
 
Net Income-9.8M-27.7M-20.3M20.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.1M28.2M30.4M34.8M
 
 
 
 
 
Shares To Calculate EPS Diluted28.1M28.2M30.4M36.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.98-$0.67$0.55
 
 
 
 
 
EPS Diluted-$0.35-$0.98-$0.67$0.55
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account